v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Operating expenses:        
Research and development expenses $ 302 $ 1,860 $ 1,080 $ 2,776
General and administrative expenses 2,700 3,092 5,578 5,792
Total operating expenses 3,002 4,952 6,658 8,568
Operating loss (3,002) (4,952) (6,658) (8,568)
Other income (expense):        
Other expense, net (1,536) (1,023) (1,826) (1,992)
Loss on equity method investment (86) (154)
Interest income 4 12
Interest expense (17) (57) (66) (233)
Total other expense, net (1,639) (1,076) (2,046) (2,213)
Net loss $ (4,641) $ (6,028) $ (8,704) $ (10,781)
Basic net loss per share $ (8.71) $ (10,940.11) $ (28.60) $ (31,615.84)
Diluted net loss per share $ (8.71) $ (10,940.11) $ (28.60) $ (31,615.84)
Basic weighted-average common shares outstanding 532,999 551 304,293 341
Diluted weighted-average common shares outstanding 532,999 551 304,293 341
Comprehensive loss:        
Foreign currency translation adjustment $ (73) $ (77) $ 174 $ (145)
Total comprehensive loss $ (4,714) $ (6,105) $ (8,530) $ (10,926)